News

rivaroxaban, Xarelto, VENTURE-AF, VKA, atrial fibrillation, Heart Rhythm 2015

Janssen Pharmaceuticals Inc. and its development partner Bayer HealthCare announced results from the VENTURE-AF trial. The study explored the potential of once-daily Xarelto (rivaroxaban) as...

botox, atrial fibrillation, cardiac surgery, HRS

A study presented at Heart Rhythm 2015 found that botulinum toxin (botox) injections into epicardial fat pads during coronary artery bypass graft (CABG) surgery can be beneficial for the patient....

Medtronic, Arctic Front, Advance Cryoablation Catheter, FDA, CE Mark

Medtronic plc announced the Arctic Front Advance ST Cryoablation Catheter has received U.S. Food and Drug Administration (FDA) approval for the treatment of patients with drug refractory,...

safe exercise level, atrial fibrillation, AF, men, women, HRS

New research reports significant differences between men and women with atrial fibrillation (AF) and the safety of intense physical activity. The study found that both moderate and vigorous levels...

HRS, early menopause, atrial fibrillation, Women's Health Study

A largest-of-its kind study has found that women who experience menopause at a younger age are at a decreased risk of atrial fibrillation (AF). The study followed nearly 18,000 women and revealed...

HRS, National Stroke Association, atrial fibrillation, AF, misperceptions, paper

A white paper published by the Heart Rhythm Society (HRS) and National Stroke Association characterizes the impact of stroke on patients with atrial fibrillation (AF) and presents common barriers...

Abbott, GE, CardioLab, RhythmView, atrial fibrillation, source

Abbott and GE Healthcare announced an agreement that will bring real-time, patient-specific data about the heart's electrical activity to cardiac electrophysiology labs. The goal of the...

May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place...

Medtronic, SYMPLICITY AF, PVI, renal denervation, Arctic Front, Spyral, G3

Medtronic plc announced the start of a clinical study to determine whether paroxysmal and persistent atrial fibrillation (AF) can be treated with a combination of two ablation procedures targeting...

Watchman, LAA, left atrial appendage

The long awaited U.S. Food and Drug Administration (FDA) approval of the first transcatheter left atrial appendage (LAA) occluder in March is seen by many cardiologists as a disruptive technology...

Johns Hopkins, motion-tracking MRI, stroke risk, atrial fibrillation

Researchers from Johns Hopkins performing sophisticated motion studies of heart magnetic resonance imaging (MRI) scans have found that specific altered function in the left atrium may signal...

Medtronic, GOLD AF Registry, PVAC GOLD, atrial fibrillation, ablation catheter

Medtronic plc announced the first patient enrollment in the GOLD AF Registry, a prospective, observational clinical study of its Phased Radiofrequency (RF) Ablation technology for treating...

catheter ablation, Afib, Amiodarone, Luigi Di Biase, ACC, heart failure

Patients with heart failure and atrial fibrillation were less likely to experience death, hospitalization or recurrent Afib with catheter ablation than with a heart rhythm-regulating drug,...

atients with atrial fibrillation (AF) who received ablation while they were already undergoing surgery to...

cryoICE, Atricure, ablation probe, cryoanalgesia, thoracotomy

AtriCure Inc. announced that it has launched the availability of its cryoICE cryo ablation probe (CRYO2) to provide cryoanalgesia for temporary pain management. AtriCure’s cryoICE is the...

CTSN, atrial fibrillation, surgical ablation, mitral valve surgery

New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ablation during mitral valve surgery reduces the occurrence of atrial fibrillation in...

Boston Scientific, Watchman LAA device, FDA approval

Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman left atrial appendage closure device. The Watchman device offers a new stroke risk reduction...

AtriCure Inc. announced the first two patients in the Dual Epicardial and Endocardial Procedure (DEEP) clinical study have been enrolled and treated at PinnacleHealth CardioVascular...

arrhythmia, heart cells, mapping, crosstalk, Johns Hopkins, Ashikaga

A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining...

atrial fibrillation, women, seniors, guidelines, blood thinners, DCRI

Nearly all women and people over 65 in the United States with atrial fibrillation are advised to take blood thinners under new guidelines based on an analysis from the Duke Clinical Research...